NCT02596100View on ClinicalTrials.gov

A Bioequivalence Study to Compare the Pharmacokinetics of Two Betrixaban Formulations

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Healthy
Interventions
DRUG

Betrixaban

Sponsors
All Listed Sponsors
lead

Portola Pharmaceuticals

INDUSTRY

NCT02596100 - A Bioequivalence Study to Compare the Pharmacokinetics of Two Betrixaban Formulations | Biotech Hunter | Biotech Hunter